E. Seifried

2.6k total citations · 1 hit paper
44 papers, 1.9k citations indexed

About

E. Seifried is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, E. Seifried has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Hematology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in E. Seifried's work include Blood properties and coagulation (12 papers), Acute Myocardial Infarction Research (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). E. Seifried is often cited by papers focused on Blood properties and coagulation (12 papers), Acute Myocardial Infarction Research (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). E. Seifried collaborates with scholars based in Germany, United Kingdom and United States. E. Seifried's co-authors include Johannes Oldenburg, Clemens R. Müller, Simone Rost, Vytautas Ivaškevičius, Knut Tore Lappegård, Edward G. D. Tuddenham, Hans‐Joachim Pelz, Andreas Fregin, Konstanze Hörtnagel and Tim M. Strom and has published in prestigious journals such as Nature, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

E. Seifried

43 papers receiving 1.8k citations

Hit Papers

Mutations in VKORC1 cause warfarin resistance and multipl... 2004 2026 2011 2018 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
    2004 857 citations Simone Rost, Vytautas Ivaškevičius et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Seifried Germany 18 779 415 367 316 302 44 1.9k
Christof Geisen Germany 21 371 0.5× 243 0.6× 218 0.6× 441 1.4× 195 0.6× 71 1.4k
Rosa Santacroce Italy 21 472 0.6× 254 0.6× 143 0.4× 341 1.1× 222 0.7× 55 1.9k
Vytautas Ivaškevičius Germany 16 552 0.7× 278 0.7× 106 0.3× 443 1.4× 237 0.8× 41 1.5k
Mojca Stegnar Slovenia 20 209 0.3× 151 0.4× 284 0.8× 321 1.0× 47 0.2× 75 1.3k
Zhaoqing Wang United States 17 167 0.2× 137 0.3× 906 2.5× 227 0.7× 122 0.4× 46 2.1k
Eva Ludwig-Schwellinger Germany 8 311 0.4× 204 0.5× 479 1.3× 68 0.2× 32 0.1× 9 1.3k
K.A. Mitropoulos United Kingdom 21 55 0.1× 305 0.7× 213 0.6× 407 1.3× 238 0.8× 40 1.3k
Cristi R. King United States 12 538 0.7× 179 0.4× 96 0.3× 52 0.2× 72 0.2× 17 1.2k
M Hanano Japan 23 226 0.3× 39 0.1× 101 0.3× 381 1.2× 65 0.2× 68 1.6k
Hans Blokzijl Netherlands 24 119 0.2× 316 0.8× 159 0.4× 46 0.1× 99 0.3× 103 2.1k

Countries citing papers authored by E. Seifried

Since Specialization
Citations

This map shows the geographic impact of E. Seifried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Seifried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Seifried more than expected).

Fields of papers citing papers by E. Seifried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Seifried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Seifried. The network helps show where E. Seifried may publish in the future.

Co-authorship network of co-authors of E. Seifried

This figure shows the co-authorship network connecting the top 25 collaborators of E. Seifried. A scholar is included among the top collaborators of E. Seifried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Seifried. E. Seifried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seifried, E. & Wolfgang Miesbach. (2012). New direct oral anticoagulants – current therapeutic options and treatment recommendations for bleeding complications. Thrombosis and Haemostasis. 108(10). 625–632. 52 indexed citations
2.
Delev, Daniel, Christof Geisen, Michael Spannagl, et al.. (2011). Molecular basis of antithrombin deficiency. Thrombosis and Haemostasis. 105(4). 635–646. 78 indexed citations
3.
Luxembourg, Beate, Katharina Schneider, Katja Sittinger, et al.. (2010). Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy. Thrombosis and Haemostasis. 105(1). 169–180. 22 indexed citations
4.
Watzka, Matthias, Christof Geisen, Carville G. Bevans, et al.. (2010). Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. Journal of Thrombosis and Haemostasis. 9(1). 109–118. 79 indexed citations
5.
Rasche, H., et al.. (2008). Klinischer Verlauf bei Cumarin-Nekrose*. DMW - Deutsche Medizinische Wochenschrift. 116(35). 1307–1312. 1 indexed citations
6.
Kreuser, E.D., et al.. (2008). Fibrinpleurodese bei malignen Pleuraergüssen. DMW - Deutsche Medizinische Wochenschrift. 110(36). 1365–1368.
7.
Ivaškevičius, Vytautas, Jerzy Windyga, Bülent Baran, et al.. (2007). Phenotype – genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia. 13(5). 649–657. 25 indexed citations
8.
Ivaškevičius, Vytautas, Michael Steffens, Christof Geisen, et al.. (2005). γAla82Gly represents a common fibrinogen γ-chain variant in Caucasians. Blood Coagulation & Fibrinolysis. 16(3). 205–208. 7 indexed citations
9.
10.
Donner, H., Christian Seidl, Harald Rau, et al.. (2002). Unbalanced amounts of HLA‐DQA1 allele mRNA: DQA1*03 shows high and DQA1*0501 low amounts of mRNA in heterozygous individuals. European Journal of Immunogenetics. 29(4). 321–330. 8 indexed citations
11.
Mueller, Markus M., et al.. (2002). Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thrombosis Research. 107. S9–S17. 36 indexed citations
12.
Seidl, Christian, Klaus Badenhoop, E. Seifried, et al.. (2001). Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients. Human Immunology. 62(5). 523–529. 27 indexed citations
13.
Meierhenrich, Rainer, et al.. (1998). Effect of reteplase on hemostasis variables: analysis of fibrin specifity, relation to bleeding complications and coronary patency. International Journal of Cardiology. 65(1). 57–63. 17 indexed citations
14.
15.
Rozdzinski, Eva, Bernd Hertenstein, T. Schmeiser, et al.. (1992). Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival. Annals of Hematology. 64(5). 245–248. 11 indexed citations
16.
Tanswell, P., et al.. (1992). Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. Journal of the American College of Cardiology. 19(5). 1071–1075. 102 indexed citations
17.
Seifried, E., et al.. (1992). Studies on the functionality of fibrinogen during rt-PA therapy. Blood Coagulation & Fibrinolysis. 3(1). 81–88. 9 indexed citations
18.
Tanswell, P., et al.. (1989). Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. Clinical Pharmacology & Therapeutics. 46(2). 155–162. 64 indexed citations
19.
Tebbe, Ulrich, et al.. (1989). Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction. The American Journal of Cardiology. 64(8). 448–453. 72 indexed citations
20.
Seifried, E., et al.. (1989). Budd-chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases. Journal of Molecular Medicine. 67(16). 818–825. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christof Geisen Breakdown of academic impact, for papers by Rosa Santacroce Breakdown of academic impact, for papers by Vytautas Ivaškevičius Breakdown of academic impact, for papers by Mojca Stegnar Breakdown of academic impact, for papers by Zhaoqing Wang Breakdown of academic impact, for papers by Eva Ludwig-Schwellinger Breakdown of academic impact, for papers by K.A. Mitropoulos Breakdown of academic impact, for papers by Cristi R. King Breakdown of academic impact, for papers by M Hanano Breakdown of academic impact, for papers by Hans Blokzijl
Rankless by CCL
2026